Patents by Inventor Jaiyanth Daniel

Jaiyanth Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8551499
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: October 8, 2013
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20130040829
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: August 13, 2012
    Publication date: February 14, 2013
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajoti Deb
  • Patent number: 8241644
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: August 14, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 8211446
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: July 3, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 8039605
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: August 25, 2009
    Date of Patent: October 18, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Patent number: 8012492
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: September 6, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Patent number: 7993658
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol synthase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: August 24, 2009
    Date of Patent: August 9, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Vinod S. Dubey, Jaiyanth Daniel
  • Publication number: 20110190479
    Abstract: The application reports the discovery that mycobacterial triacylglycerol synthase (MTTGS) enzymes also have a wax synthase function. This bifunctional enzymatic activity, or ‘dual function,’ implies that the enzymes contain separate binding sites for diacylglycerol and acyl alcohol and a common binding site for acyl-coenzyme A. Embodiments of the invention relate to methods of selection and/or design of therapeutic compounds that will reduce any potentially toxic side effects of candidate drugs designed to inhibit the mycobacterial enzyme.
    Type: Application
    Filed: January 3, 2011
    Publication date: August 4, 2011
    Inventors: PAPPACHAN E. KOLATTUKUDY, TATIANA SIRAKOVA, VINOD S. DUBEY, JAIYANTH DANIEL
  • Publication number: 20110033915
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: August 30, 2010
    Publication date: February 10, 2011
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20110033914
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: August 30, 2010
    Publication date: February 10, 2011
    Applicant: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20100021453
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol synthase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Application
    Filed: August 24, 2009
    Publication date: January 28, 2010
    Inventors: Pappachan E. Kolattukudy, Tatiana Sirakova, Vinod S. Dubey, Jaiyanth Daniel
  • Publication number: 20100008903
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Application
    Filed: August 25, 2009
    Publication date: January 14, 2010
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Patent number: 7601357
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: October 13, 2009
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Patent number: 7579012
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol synthase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: August 25, 2009
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Pappachan E. Kolattukudy, Tatiano Sirakova, Vinod S. Dubey, Jaiyanth Daniel
  • Publication number: 20090023596
    Abstract: A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it to multiple stress conditions, including a low nutrient culture medium without glycerol, a low pH, a relatively high level of carbon dioxide and a relatively low gas phase oxygen level. An in vitro model of mycobacterial infection employs macrophages induced from THP1 cells which are then infected with Mycobacterium. The infected macrophages are grown under hypoxic conditions to induce latency in the mycobacteria. The in vitro model of infection is useful in evaluating compounds for activity against latent mycobacteria.
    Type: Application
    Filed: April 22, 2008
    Publication date: January 22, 2009
    Inventors: Pappachan Kolattukudy, Tatiana Sirakova, Jaiyanth Daniel, Chirajyoti Deb
  • Publication number: 20070161562
    Abstract: Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol hydrolase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
    Type: Application
    Filed: November 20, 2006
    Publication date: July 12, 2007
    Inventors: Pappachan Kolattukudy, Chirajyoti Deb, Jaiyanth Daniel
  • Publication number: 20030176540
    Abstract: This invention relates to a novel synergistic reversible solid/semi-solid organic composition, said composition comprising (a) at least one saturated long chain fatty acid and/or its glycerol esters and (b) one or more liquid neutral organic compounds, said ingredients (a) and (b) being present in a ratio between 0.1 to 40% by weight, and a process for producing said synergistic reversible solid/semi-solid organic composition by mixing the ingredients (a) and (b) defined above in a ratio between 0.1 to 40% by weight, at a temperature between 2 to 50° C. and at a pressure in the range of 200 torr to 2500 torr.
    Type: Application
    Filed: May 15, 2002
    Publication date: September 18, 2003
    Inventors: Ram Rajasekharan, Jaiyanth Daniel
  • Patent number: 6391928
    Abstract: This invention relates to a novel synergistic reversible solid/semi-solid organic composition, said composition comprising (a) at least one saturated long chain fatty acid and/or its glycerol esters and (b) one or more liquid neutral organic compounds, said ingredients (a) and (b) being present in a ratio between 0.1 to 40% by weight, and a process for producing said synergistic reversible solid/semi-solid organic composition by mixing the ingredients (a) and (b) defmed above in a ratio between 0.1 to 40% by weight, at a temperature between 2 to 50° C. and at a pressure in the range of 200 torr to 2500 torr.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: May 21, 2002
    Assignees: Indian Institute of Science, Nagarjuna Holding Private Limited
    Inventors: Ram Rajasekharan, Jaiyanth Daniel